MedTrace Logo

Hypertonic Saline Inhalation in Acute Bronchiolitis

NCT03880903 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2020-02-11

No results posted yet for this study

Summary

Acute bronchiolitis is a viral infection that occurs in children most commonly in the first 2 years of life and is characterized by respiratory symptoms, resulting in wheezing and/or crackles upon auscultation. It is usually a self limiting illness. However, this condition may be associated with several severe complications, such as apnea,respiratory failure, or secondary bacterial infection

Conditions

  • Acute Bronchiolitis

Interventions

DRUG

normal saline and salbutamol

patients will recieve treatment with nebulized salbutamol and normal saline every 4 to 6 in hours

DRUG

hypertonic saline and salbutamol

patients will recieve treatment with nebulized salbutamol and hypertonic saline 3% in adose of 4ml every 4 to 6 hours

DRUG

Hypertonic saline

patients will recieve treatment with nebulized hypertonic saline 3% in adose of 4ml every 4 to 6 hours

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
24 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-20
Primary Completion
2021-03-20
Completion
2021-09-20

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03880903 on ClinicalTrials.gov